Compare RNAC & ERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNAC | ERC |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.2M | 259.5M |
| IPO Year | 2016 | N/A |
| Metric | RNAC | ERC |
|---|---|---|
| Price | $6.35 | $9.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 134.3K | 61.4K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.37% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | ★ $2,797,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.60 | $8.72 |
| 52 Week High | $14.56 | $9.78 |
| Indicator | RNAC | ERC |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 58.84 |
| Support Level | $5.89 | $9.25 |
| Resistance Level | $6.60 | $9.50 |
| Average True Range (ATR) | 0.42 | 0.13 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 76.38 | 94.83 |
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.